Pathways and intermediates of amyloid fibril formation.

The lack of understanding of amyloid fibril formation at the molecular level is a major obstacle in devising strategies to interfere with the pathologies linked to peptide or protein aggregation. In particular, little is known on the role of intermediates and fibril elongation pathways as well as their dependence on the intrinsic tendency of a polypeptide chain to self-assembly by beta-sheet formation (beta-aggregation propensity). Here, coarse-grained simulations of an amphipathic polypeptide show that a decrease in the beta-aggregation propensity results in a larger heterogeneity of elongation pathways, despite the essentially identical structure of the final fibril. Protofibrillar intermediates that are thinner, shorter and less structured than the final fibril accumulate along some of these pathways. Moreover, the templated formation of an additional protofilament on the lateral surface of a protofibril is sometimes observed as a collective transition. Conversely, for a polypeptide model with a high beta-aggregation propensity, elongation proceeds without protofibrillar intermediates. Therefore, changes in intrinsic beta-aggregation propensity modulate the relative accessibility of parallel routes of aggregation.

[1]  C. Dobson,et al.  Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. , 2005, Journal of molecular biology.

[2]  Joan-Emma Shea,et al.  Self-assembly of β-sheet forming peptides into chiral fibrillar aggregates , 2007 .

[3]  R. Jansen,et al.  Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy. , 2005, Biophysical journal.

[4]  Gerhard Hummer,et al.  Molecular dynamics simulations of Alzheimer's β-amyloid protofilaments , 2005 .

[5]  R. Wetzel,et al.  Polymorphism in the intermediates and products of amyloid assembly. , 2007, Current opinion in structural biology.

[6]  N. Dokholyan,et al.  A single disulfide bond differentiates aggregation pathways of beta2-microglobulin. , 2005, Journal of molecular biology.

[7]  Brigita Urbanc,et al.  In silico study of amyloid β-protein folding and oligomerization , 2004 .

[8]  G. Damaschun,et al.  Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation. , 2003, Journal of molecular biology.

[9]  C. Hall,et al.  Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Broglia,et al.  Folding and aggregation of designed proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Caflisch,et al.  The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Wetzel,et al.  Thermodynamics of Aβ(1−40) Amyloid Fibril Elongation† , 2005 .

[13]  San Francisco,et al.  Thermodynamics of Model Prions and its Implications for the Problem of Prion Protein Folding , 1999 .

[14]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Selkoe,et al.  Title Amyloid β-protein fibrillogenesis . Structure and biological activity of protofibrillar intermediates , 1999 .

[16]  P. Lansbury,et al.  A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.

[17]  L. Mucke,et al.  Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation , 2004, Nature Medicine.

[18]  Sampling the self-assembly pathways of KFFE hexamers. , 2004, Biophysical journal.

[19]  F. Rao,et al.  The protein folding network. , 2004, Journal of molecular biology.

[20]  S. Radford,et al.  Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. , 2005, Journal of molecular biology.

[21]  A. Cavalli,et al.  The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates , 2004, Protein science : a publication of the Protein Society.

[22]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Roger D Kamm,et al.  Kinetic control of dimer structure formation in amyloid fibrillogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[25]  D Thirumalai,et al.  Monomer adds to preformed structured oligomers of Aβ-peptides by a two-stage dock–lock mechanism , 2007, Proceedings of the National Academy of Sciences.

[26]  L. Serrano,et al.  Sequence dependence of amyloid fibril formation: insights from molecular dynamics simulations. , 2005, Journal of molecular biology.

[27]  D. Thirumalai,et al.  Exploring protein aggregation and self‐propagation using lattice models: Phase diagram and kinetics , 2002, Protein science : a publication of the Protein Society.

[28]  C. Dobson Protein folding and misfolding , 2003, Nature.

[29]  George B. Benedek,et al.  Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .

[30]  M. Gobbi,et al.  Gerstmann-Sträussler-Scheinker Disease Amyloid Protein Polymerizes According to the “Dock-and-Lock” Model* , 2006, Journal of Biological Chemistry.

[31]  M. J. Parker,et al.  Amyloid formation under physiological conditions proceeds via a native-like folding intermediate , 2006, Nature Structural &Molecular Biology.

[32]  R. Murphy Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins. , 2007, Biochimica et biophysica acta.

[33]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[34]  P. Gupta,et al.  Effect of denaturant and protein concentrations upon protein refolding and aggregation: A simple lattice model , 1998, Protein science : a publication of the Protein Society.

[35]  Feng Ding,et al.  Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases , 2005, PLoS Comput. Biol..

[36]  Francesca Massi,et al.  Energy landscape theory for Alzheimer's amyloid β‐peptide fibril elongation , 2001 .

[37]  Yaoqi Zhou,et al.  Assembly and kinetic folding pathways of a tetrameric beta-sheet complex: molecular dynamics simulations on simplified off-lattice protein models. , 2004, Biophysical journal.

[38]  Lucjan Piela,et al.  Theoretical model of prion propagation: A misfolded protein induces misfolding , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Christopher M. Dobson,et al.  Molecular recycling within amyloid fibrils , 2005, Nature.

[40]  J. Kelly,et al.  The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.

[41]  Amedeo Caflisch,et al.  Network and graph analyses of folding free energy surfaces. , 2006, Current opinion in structural biology.

[42]  A. Fersht Structure and mechanism in protein science , 1998 .

[43]  Amedeo Caflisch,et al.  Interpreting the aggregation kinetics of amyloid peptides. , 2006, Journal of molecular biology.

[44]  D. Thirumalai,et al.  Dissecting the assembly of A β 16-22 amyloid peptides into antiparallel β-sheets , 2002 .

[45]  J R Ghilardi,et al.  Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. , 2000, Biochemistry.

[46]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[47]  R. Nussinov,et al.  Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ16–22, Aβ16–35, and Aβ10–35): Sequence effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[49]  C. Dobson,et al.  A toy model for predicting the rate of amyloid formation from unfolded protein. , 2005, Journal of molecular biology.